What Halo Neuroscience does

Halo Neuroscience is a San Francisco-based neurotechnology company founded in 2014 that developed the Halo Sport brain stimulator, a wearable headset utilizing transcranial Direct Current Stimulation (tDCS) technology to accelerate muscle memory development for athletic and fitness applications. The company's single core product is positioned as a consumer wellness device available without prescription, priced at approximately US$600, and uses tDCS hardware identical to that found in its parent company's FDA-approved medical device. Halo Neuroscience was acquired by Flow Neuroscience in 2021, and the Halo brand continues to operate as the consumer wellness arm under Flow's corporate umbrella.

The company operates a direct-to-consumer go-to-market model, selling exclusively through its e-commerce storefront at haloneuro.com to athletes and fitness enthusiasts seeking faster motor learning and skill acquisition. Revenue is generated through one-time hardware sales of the Halo Sport headset, with no subscription, software, or service revenue streams disclosed. The company targets a horizontal consumer segment—individuals interested in performance enhancement through neurostimulation—with marketing concentrated on organic social media channels, primarily X (Twitter), where the brand maintains approximately 4,065 followers.

Since the 2021 acquisition, Halo Neuroscience has functioned as a subsidiary brand under Flow Neuroscience, which holds FDA approval for a tDCS device in depression treatment. Halo's product is explicitly marketed as a wellness device rather than a medical product, positioning it in a regulatory gray zone that avoids prescription requirements but also precludes clinical claims. The company has no documented enterprise customers, no disclosed revenue figures, and has not raised independent funding since April 2018, suggesting limited standalone operational expansion post-acquisition.

Name

Halo Neuroscience

Legal name

Halo Neuroscience

Website

https://haloneuro.com

Company type

Private

Founded year

2014

Operating status

Acquired

Headcount range

11–50 employees

Short description

Halo Neuroscience is a San Francisco-based neurotech company that developed the Halo Sport tDCS brain stimulator headset for athletes and fitness enthusiasts to accelerate muscle memory development. Acquired by Flow Neuroscience in 2021, it now operates as a consumer wellness sub-brand selling direct via e-commerce at ~$600 per device.

Ownership category

akta.pro rank

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D

Revenue model

1. Hardware Sales: Sale of the Halo Sport brain stimulation device as a one-time hardware purchase, marketed as a wellness product without prescription.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Halo Neuroscience develops and sells the Halo Sport, a transcranial direct current stimulation (tDCS) headset that helps users develop muscle memory faster. The device is sold directly to consumers as a non-prescription wellness product for approximately US $600, leveraging tDCS hardware identical to Flow Neuroscience's FDA-approved medical device.

Product overview

Halo Neuroscience is a single-product company that developed and marketed Halo Sport, a wearable tDCS headset. The company was acquired by Flow Neuroscience in 2021. Under the Halo Neuroscience brand, Flow currently sells a headset with identical tDCS hardware marketed as a wellness device.

Differentiator

Problem solved

Functional benefit

Brands

• Halo Sport: Brain stimulator product that helps users develop muscle memory faster using tDCS technology.

Products and services

• Halo Sport A wearable transcranial Direct Current Stimulation (tDCS) headset marketed as a consumer wellness device that helps users develop muscle memory faster, sold without prescription for approximately US $600 to athletes and fitness enthusiasts.

Quantifiable outcome

• 58% of participants responded to treatment vs 38% in sham group in Flow's pivotal trial (for medical tDCS device)

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Flow NeurosciencecoreOthers · 1 January 2021Flow Neuroscience acquired Halo Neuroscience in 2021. Under the Halo brand name, the company currently sells a headset using identical tDCS hardware to Flow's FDA-approved medical device, but marketed as a wellness device without prescription. This acquisition established Flow as the parent company controlling both the medical/prescription and consumer wellness segments of the tDCS brain stimulation market.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Modius (Neurovalens): Consumer neurostimulation headset targeting weight management, sleep, and metabolic health. Comparable in being a DTC consumer tDCS-adjacent device targeting wellness outcomes with regulatory positioning.
• Apollo Neuroscience: Consumer wearable neurostimulation device targeting stress, sleep, and focus using vibrotactile stimulation. Directly competes in the consumer neurotech/wellness hardware category with a similar DTC premium pricing model.
• Flow Neuroscience: Parent company of Halo Neuroscience and maker of the FDA-approved at-home tDCS device for depression. Uses identical underlying tDCS hardware as Halo Sport but sells as a regulated medical prescription product, making it the most direct comparable.
• Muse (Interaxon): Consumer EEG-based brain-sensing headband for meditation and cognitive performance. Competes for the same biohacker and self-optimization customer segment using a different neurotechnology modality (EEG vs tDCS).
• Thync: Earlier-stage consumer neurostimulation company that developed wearable devices for stress and energy using transcranial electrical stimulation. Closely comparable technology stack and wellness positioning, though Thync's consumer traction has been limited.

Broad incumbents

• Hyperice: Established consumer recovery and performance technology brand (vibration, percussion, heat/cold therapy). Targets the same athletic performance and muscle recovery customer segment with adjacent hardware-based solutions.
• Compex (DJO Global): Established electronic muscle stimulation (EMS) brand for athletic training and recovery. Comparable in delivering electrical stimulation to enhance muscle performance, but using peripheral rather than transcranial stimulation.
• Electrocore (now part of Axonics): Medical device company with FDA-cleared non-invasive vagus nerve stimulation technology. Comparable in being a regulated neurostimulation hardware company, though targeting different therapeutic indications.

Emerging players

• Neurable: Consumer-oriented brain-computer interface company with EEG-based headphones and focus products. Comparable in targeting the same consumer neurotech category with premium hardware positioning.
• Dreem: Consumer neurotechnology headband focused on sleep optimization using EEG and bone conduction. Competes for overlapping self-optimization and wellness consumer dollars with a different technological approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks7 records

Key highlights5 records

Customer concentration

• Xx.com/HaloNeuro
• Facebookfacebook.com/halo.neuroscience
• LinkedInlinkedin.com/company/halo-neuroscience

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds6 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Halo Neuroscience